Citadel Advisors
TLOG

Citadel Advisors’s TetraLogic Pharmaceuticals Corporation TLOG Stock Holding History

Citadel Advisors’s Portfolio TLOG Stock Details TLOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-27,442
Closed -$4K – 8347
2016
Q3 		$4K Buy
+27,442
New +$6.34K ﹤0.01% 7161

Other funds holding TLOG

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
BWA
Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Citadel Advisors's TLOG Position: Q4 2016 in Review

Citadel Advisors sold out of TetraLogic Pharmaceuticals Corporation (TLOG) in Q4 2016, closing a stake of 27,442 shares — an estimated $4K sold.

Citadel Advisors first reported a position in TLOG in Q3 2016 and held it in 1 quarter. The position peaked at $4K in Q3 2016. 3 funds tracked by Wall St. Rank hold TLOG as of Q4 2016.

  • Citadel Advisors reported no remaining TetraLogic Pharmaceuticals Corporation position as of Q4 2016 after selling out during the quarter.
  • Citadel Advisors sold 27,442 TetraLogic Pharmaceuticals Corporation shares in Q4 2016, an estimated $4K.
  • Citadel Advisors first reported a position in TetraLogic Pharmaceuticals Corporation in Q3 2016 and held it in 1 quarter.
  • Citadel Advisors's TetraLogic Pharmaceuticals Corporation position peaked at $4K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held TetraLogic Pharmaceuticals Corporation as of Q4 2016.

Based on Citadel Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.